Basic Information
| LncRNA/CircRNA Name | circ_0000092 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Dual luciferase reporter, RNA pull-down and northern blot assays |
| Sample | liver cancer tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | Moreover, depleted hsa_circ_0000092 or elevated miR-338-3p was shown to suppress HCC cell proliferation, migration, invasion and angiogenesis in vitro via down-regulation of HN1. |
| Pubmed ID | 32077624 |
| Year | 2020 |
| Title | hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p |
External Links
| Links for circ_0000092 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |